||Betes M, Munoz-Navas MA, Duque JM et al: Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol; 98: 2648–2654, 2003.
Crotta S, Castiglione G, Grazzini G, Valle F, Mosconi S & Rosset R. Feasibility study of colorectal cancer screening by immunochemical faecal occult blood testing: results in a northern Italian community, Eur.J.Gastroenterol.Hepatol., vol. 16, no. 1, pp. 33-37,2004.
Denberg TD, Melhado TV, Coombes JM, Beaty BL, Berman K, Byers TE, Marcus AC, Steiner JF & Ahnen DJ: Predictors of nonadherence to screening colonoscopy, J.Gen.Intern.Med., vol. 20, no. 11, pp. 989-995,2005.
Everett T, Bryant A, Griffin MF, Martin-Hirsch PP, Forbes CA, Jepson RG, Interventions targeted at women to encourage the uptake of cervical screening, Cochrane Database Syst Rev. May 11;(5), 2011.
Federici A, Giorgi RP, Bartolozzi F, Farchi S, Borgia P & Guastcchi G, The role of GPs in increasing compliance to colorectal cancer screening: a randomised controlled trial (Italy), Cancer Causes Control, vol. 17, no. 1, pp. 45-52, 2006.
Fenocchi E, Martinez L, Tolve J, Montano D, Rondan M, Parra-Blanco A & Eishi Y, Screening for colorectal cancer in Uruguay with an immunochemical faecal occult blood test, Eur.J.Cancer Prev., vol. 15, no. 5, pp. 384-390, 2006.
Fournel I, Cottet V, Binquet C, Jooste V, Faivre J, Bouvier AM, Bonithon-Kopp C, Rural-urban inequalities in detection rates of colorectal tumours in the population, Dig Liver Dis, Feb;44(2):172-7, 2012.
Frederiksen B L, Jørgensen T, Brasso K, Holten I, and Osler M. Socioeconomic position and participation in colorectal cancer screening. Br J Cancer. November 9; 103(10): 1496–1501. 2010.
Grazzini G, Castiglione G, Ciabattoni C, Franceschini F, Giorgi D, Gozzi S, Mantellini P, Lopane P, Perco M, RubecaT, Salvadori P, Visioli CB & Zappa M, Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results, Eur.J.Cancer Prev., vol. 13, no. 1, pp. 19-26, 2004.
Haiyun Yang, Zhizheng Ge, Jun Dai,Xiaobo Li, Yunjie Gao: Effectiveness of the Immunofecal Occult Blood Test for Colorectal Cancer Screening in a Large PopulationDig Dis Sci, 56:203–207,2011.
Hol L, van Leerdam ME, van BM, van Vuuren AJ, van DH, Reijerink JC, van der Togt AC, Habbema JD & Kuipers EJ, Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy, Gut, vol. 59, no. 1, pp. 62-68, 2010.
Kahl CJ, Imperiale TF, Juliar BE, Rex DK. Effect of screening colonoscopy on colorectal cancer incidence and mortality, Clin. Gastroenterol. Hepatol., vol.7, 7, 770-775, 2009.
Levi Z, Birkenfeld S, Vilkin A et al.: A higher detection rate for colorectal cancer and advanced adenomatous polyp for screening with immunochemical fecal occult blood test than guaiac fecal occult blood test, despite lower compliance rate. A prospective, controlled, feasibility study, Int. J. Cancer: 128, 2415–2424, 2011.
Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y: A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology; 129:422–428, 2005.
Popescu A, Sporea I: Screeningul cancerului de colon intre ideal si posibilitati; 9-20; 45-103 Editura Mirton, 2009.
Quirke P, Risio M, Lambert R, von Karsa L, Vieth M. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition-Quality assurance in pathology in colorectal cancer screening and diagnosis, Endoscopy, Sep; 44 Suppl 3:SE116-30, 2012.
Sabesan S, Piliouras P, Disparity in cancer survival between urban and rural patients–how can clinicians help reduce it? Rural Remote Health. Jul-Sep;9(3):1146. Epub 2009 Jul 17, 2009.
Saito H, Colorectal cancer screening using immunochemical faecal occult blood testing in Japan, J.Med.Screen., vol. 13 Suppl 1, p. S6-S7, 2006.
Vijan S, Hwang EW, Hofer TP, Hayward RA. Which colon cancer screening test? a comparison of costs, effectiveness, and compliance. Am J Med.; 111 (8):593–601, 2001.
van Rossum LGM, van Rijn AF, Laheij RJF, et al: Cut-off value determines the performance of a semi-quantitative immunochemical faecal occult blood test in a colorectal cancer screening programme. British Journal of Cancer; 101: 1274 – 1281, 2009.
Wallace PM, Suzuki R. Regional, racial, and gender differences in colorectal cancer screening in middle-aged African-Americans and Whites. J Cancer Educ. Dec;27(4):703-8, 2012.
Zorzi M, Falcini F, Fedato C, Grazzini G, de’ Bianchi PS, Senore C, Vettorazzi M, Visioli C, Zappa M. Screening for colorectal cancer in Italy: 2006 survey. Epidemiol Prev. Mar-Apr;32(2 Suppl 1):55-68, 2008 .